Back

Quantitative angiographic analysis in patients with de novo native coronary artery lesions treated with novel poly-l-lactide based sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 Trial

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Bioresorbable vascular scaffolds: still the future or already the past? PCI / stents: devices and technique ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Praveen Chandra

Gurgaon (India)

9 More presentations in this session

Presentation thumbnail
Early and Late target lesion failure and thrombosis after implantation of coronary bioresorbable scaffolds: analysis of predictors and mechanisms.
Doctor T. Gori (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Major coronary evaginations following implantation of bioresorbable vascular scaffolds: clinical and OCT characteristics
Doctor F. Blachutzik (Giessen, DE)
Abstract Slides Video
Presentation thumbnail
One-year clinical outcomes following bioresorbable vascular scaffold implantation in patients presenting with acute coronary syndromes versus stable coronary artery disease: results from RAI registry
Doctor E. Moscarella (Caserta, IT)
Abstract Slides Video
Presentation thumbnail
Bioresorbable vascular scaffolds versus metallic stents in patients with STsegment
Doctor T. Kofler (Altdorf, CH)
Abstract Slides Video
Presentation thumbnail
Computed Tomography Coronary Angiography Long-term Results of Bioresorbable Vascular Scaffold in clinical practice. A BVS-Expand project
Professor R. van Geuns (Nijmegen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Bioresorbable vascular scaffolds: still the future or already the past?

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources